Subject(s)
COVID-19 , Herpes Zoster , Adenoviridae , COVID-19 Vaccines , Herpes Zoster/prevention & control , Humans , SARS-CoV-2ABSTRACT
As COVID-19 vaccination has started worldwide to control this pandemic, dermatologists may face various challenges with these new vaccines. In this manuscript, we review different types of available COVID-19 vaccines and their various production platforms. Vaccination considerations in patients with skin diseases, especially those using immunomodulatory drugs will be presented. Finally, adverse cutaneous reactions of COVID-19 vaccines will be reviewed.
Subject(s)
COVID-19 , Vaccines , COVID-19 Vaccines , Dermatologists , Humans , SARS-CoV-2 , Vaccines/adverse effectsABSTRACT
Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19.